VXM COVID-19

N/A

Report date: 2025/03/20 09:47:14

Base Information

Drug NameVXM COVID-19

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaximm AG

China Registration ClassN/A

Develop Information

Active CompaniesVaximm AG

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A